Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs

Alzheimer’s disease (AD) is the most common form of dementia, with a high impact worldwide, accounting for more than 46 million cases. The continuous increase of AD demands the fast development of preventive and curative therapeutic strategies that are truly effective. The drugs approved for AD trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunes, Débora, Loureiro, Joana A., Pereira, Maria Carmo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694621/
https://www.ncbi.nlm.nih.gov/pubmed/36365114
http://dx.doi.org/10.3390/pharmaceutics14112296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694621/
https://www.ncbi.nlm.nih.gov/pubmed/36365114
http://dx.doi.org/10.3390/pharmaceutics14112296

Ejemplares similares